Marta Lorenzo

Dr. Marta Lorenzo


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2025 in Brain Sciences
Verified
Journal Article
Open access
PDF file
MRMehdi Rashidi
Mehdi Rashidi
SASerena Arima
Serena Arima
ASAndrea Claudio Stetco
Andrea Claudio Stetco
CCChiara Coppola
Chiara Coppola
DMDebora Musarò
Debora Musarò
MICHELE MAFFIAMICHELE MAFFIA
MICHELE MAFFIA
Background: Parkinson’s disease (PD) is the second most common neurodegenerative disorder after Alzheimer’s disease, affecting countless individuals worldwide. PD is characterized by the onset of a marked motor symptomatology in association with several non-motor manifestations. The clinical phase of the disease is usually preceded by a long prodromal phase, devoid of overt motor symptomatology but often showing some conditions such as sleep disturbance, constipation, anosmia, and phonatory changes. To date, speech analysis appears to be a promising digital biomarker to anticipate even 10 years before the onset of clinical PD, as well serving as a useful prognostic tool for patient follow-up. That is why, the voice can be nominated as the non-invasive method to detect PD from healthy subjects (HS). Methods: Our study was based on cross-sectional study to analysis voice impairment. A dataset comprising 81 voice samples (41 from healthy individuals and 40 from PD patients) was utilized to train and evaluate common machine learning (ML) models using various types of features, including long-term (jitter, shimmer, and cepstral peak prominence (CPP)), short-term features (Mel-frequency cepstral coefficient (MFCC)), and non-standard measurements (pitch period entropy (PPE) and recurrence period density entropy (RPDE)). The study adopted multiple machine learning (ML) algorithms, including random forest (RF), K-nearest neighbors (KNN), decision tree (DT), naïve Bayes (NB), support vector machines (SVM), and logistic regression (LR). Cross-validation technique was applied to ensure the reliability of performance metrics on train and test subsets. These metrics (accuracy, recall, and precision), help determine the most effective models for distinguishing PD from healthy subjects. Result: Among all the algorithms used in this research, random forest (RF) was the best-performing model, achieving an accuracy of 82.72% with a ROC-AUC score of 89.65%. Although other models, such as support vector machine (SVM), could be considered with an accuracy of 75.29% and a ROC-AUC score of 82.63%, RF was by far the best one when evaluated across all metrics. The K-nearest neighbor (KNN) and decision tree (DT) performed the worst. Notably, by combining a comprehensive set of long-term, short-term, and non-standard acoustic features, unlike previous studies that typically focused on only a subset, our study achieved higher predictive performance, offering a more robust model for early PD detection. Conclusions: This study highlights the potential of combining advanced acoustic analysis with ML algorithms to develop non-invasive and reliable tools for early PD detection, offering substantial benefits for the healthcare sector.

9 April 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
MRMehdi Rashidi
Mehdi Rashidi
SASerena Arima
Serena Arima
ASAndrea Claudio Stetco
Andrea Claudio Stetco
CCChiara Coppola
Chiara Coppola
DMDebora Musarò
Debora Musarò
MICHELE MAFFIAMICHELE MAFFIA
MICHELE MAFFIA
Background: Parkinson’s disease (PD) is the second most common neurodegenerative disorder after Alzheimer’s disease affecting countless individuals worldwide. PD is characterized by the onset of a marked motor symptomatology in association with several nonmotor manifestations. The clinical phase of the disease is usually preceded by a long prodromal phase, devoid of overt motor symptomatology but often showing some conditions such as sleep disturbance, constipation, anosmia, and phonatory changes. To date, speech analysis appears to be a promising digital biomarker to anticipate even 10 years the onset of clinical PD, as well serving as a useful prognostic tool for patient follow-up. That is why, the voice can be nominated as the non-invasive method to detect PD from healthy subjects (HS).

13 August 2026 in Bioengineering
Verified
Journal Article
Open access
PDF file
MRMehdi Rashidi
Mehdi Rashidi
SSSyed Adil Hussain Shah
Syed Adil Hussain Shah
MGMarco Greco
Marco Greco
CCChiara Coppola
Chiara Coppola
Andrea BuccolieroAndrea Buccoliero
Andrea Buccoliero
MICHELE MAFFIAMICHELE MAFFIA
MICHELE MAFFIA
Introduction: Voice-based digital biomarkers have emerged as a promising approach for distinguishing individuals with neurodegenerative disorders, particularly Parkinson’s disease (PD), from healthy subjects (HS). With the increasing availability of smartphone and web-based recording tools, voice data can be collected efficiently in both clinical and remote settings. However, further validation is required before such approaches can be translated into routine clinical practice. Methods: This study used a cross-sectional analysis at the recording level, treating repeated recordings from the same participant as separate observations collected at Vito Fazzi Hospital in Lecce, Italy. Speech recordings from individuals with Parkinson’s disease (PD) and healthy controls were collected using the dedicated Talia smartphone and web application. Sustained vowel phonation (/a/) was analyzed as the primary speech task. Following data acquisition, feature extraction was performed as a crucial step in the speech analysis pipeline, as the quality and relevance of the extracted features directly influence the ability of machine learning models to discriminate between Parkinson’s disease (PD) patients and healthy controls. To capture various aspects of speech impairment associated with PD, a comprehensive set of acoustic features was extracted, including long-term features (pitch, jitter, and shimmer), nonlinear descriptors such as Recurrence Period Density Entropy (RPDE), and short-term feature based on Mel-Frequency Cepstral Coefficients (MFCCs). These features were subsequently used to develop and evaluate machine learning models for the classification of Parkinson’s disease and healthy subjects. Feature selection was performed using SHAP to identify the most informative vocal biomarkers. Model performance was assessed using five independent random train–test splits (70% training and 30% testing), supported by an internal five-fold cross-validation procedure within the training data. Multiple machine learning models were developed and evaluated, including Random Forest, Logistic Regression, Support Vector Machine, Naive Bayes, K-Nearest Neighbors, Decision Tree, Artificial Neural Network, and Gradient Boosting. Results: The evaluated models demonstrated strong recording-level classification performance. Artificial Neural Networks (ANN) and K-Nearest Neighbors (KNN) achieved the highest accuracy scores (0.9545 and 0.9494, respectively), along with superior recall (up to 0.9500), precision (up to 0.9551), and F1-score (up to 0.9525). Both models also exhibited excellent discriminative ability, with ROC-AUC values reaching 0.9882 (ANN) and 0.9893 (KNN). In contrast, Naive Bayes and Decision Tree showed comparatively lower performance across all metrics. Log-loss analysis further confirmed the robustness of ANN and KNN, which achieved the lowest values (0.2552 and 0.2510, respectively), indicating well-calibrated predictions. Overall, the findings highlight the consistency and generalizability of ANN and KNN across cross-validation splits. Conclusions: This study demonstrates that machine learning models, particularly ANN and KNN, can effectively differentiate Parkinson’s disease from healthy conditions using voice recordings. The integration of explainable AI for feature selection enhances model transparency and clinical relevance. However, the reported performance estimates were obtained from a recording-level analysis and should be interpreted as preliminary findings. Further studies involving larger cohorts and participant-level validation strategies are required to determine the generalizability and clinical applicability of these approaches.

11 September 2026 in Bioengineering
Verified
Journal Article
Open access
PDF file
MRMehdi Rashidi
Mehdi Rashidi
SSSyed Adil Hussain Shah
Syed Adil Hussain Shah
MGMarco Greco
Marco Greco
MLMarta Lorenzo
Marta Lorenzo
Andrea BuccolieroAndrea Buccoliero
Andrea Buccoliero
MICHELE MAFFIAMICHELE MAFFIA
MICHELE MAFFIA
Introduction: Voice-based digital biomarkers have emerged as a promising, non-invasive approach for the early detection and monitoring of neurodegenerative disorders, particularly Parkinson’s disease (PD). Although voice recordings can be acquired easily using mobile health technologies, their integration into routine clinical practice remains limited due to challenges related to model interpretability and clinical validation. This study aimed to investigate the diagnostic potential of voice recordings acquired through the TALIA smartphone and web-based platform and to improve model transparency using explainable artificial intelligence (XAI) techniques. Methods: Voice recordings from participants with PD and control group (CG) were acquired over a six-month period using the TALIA digital-health platform at Vito Fazzi Hospital in Lecce, Italy. The data were evaluated cross-sectionally at the recording level. Sustained vowel (/a/) phonations were preprocessed and transformed into spectrogram images. A transfer-learning framework based on the pre-trained VGGish convolutional neural network (VGGish-CNN) was developed to classify PD and CG voice recordings. To enhance interpretability, explainable artificial intelligence (XAI) methods, including Local Interpretable Model-Agnostic Explanations (LIME) and Occlusion Sensitivity, were integrated to identify the spectro-temporal regions contributing most strongly to model predictions. Results: The proposed VGGish-CNN framework demonstrated excellent classification performance in distinguishing PD from CG. The model achieved an accuracy of 0.93, precision of 0.91, recall of 0.95, F1-score of 0.93, loss of 0.16, and an area under the receiver operating characteristic curve (AUC) of 0.987. XAI analyses provided qualitative, sample-specific visualizations of the spectro-temporal regions contributing to individual model predictions, thereby improving the transparency and interpretability of the deep-learning model. Conclusions: The findings demonstrate that a transfer-learning approach based on VGGish-CNN could achieve promising recording-level classification performance in distinguishing voice recordings from participants with PD and CG within this pilot dataset. Furthermore, XAI techniques provide qualitative insight into the model’s decision-making process. These preliminary findings support further investigation of voice-based approaches for PD screening in larger cohorts using participant-level and external validation.


17 October 2025 in Surgical Neurology International
Verified
Journal Article
Open access
SASohaib Ali
Sohaib Ali
AMAlessandro Melatini
Alessandro Melatini
CGCosimo Damiano Gianfreda
Cosimo Damiano Gianfreda
DCDomenico Cassitto
Domenico Cassitto
AGAlessandra Giaquinta
Alessandra Giaquinta
HSHaleema Sadia
Haleema Sadia
Background: Holmes tremor (HT) is a rare, low-frequency tremor that presents at rest, during posture maintenance, and with intentional movement – associated with structural damage to the midbrain, thalamus, or cerebellothalamic pathways. Although vascular causes are well established, HT resulting from mesencephalic hemorrhage complicated by obstructive hydrocephalus has not been previously reported in the literature. Case Description: A 71-year-old male developed acute left hemiparesis and dysarthria following traumatic brain injury. Neuroimaging revealed right ponto-mesencephalic hemorrhage extending into the superior cerebellar peduncle, with infarction near the right tentorial edge and compression of the fourth ventricle, leading to supratentorial hydrocephalus. One-week post-trauma, the patient exhibited a right-sided tremor with resting, postural, and kinetic components, consistent with HT. Pharmacologic treatments, including antiepileptics, failed to produce clinical improvement. Serial imaging ruled out vascular malformations. Given patient’s progressive neurological recovery, a non-surgical, conservative management strategy was adopted. Conclusion: This case highlights a rare manifestation of HT secondary to mesencephalic hemorrhage complicated by obstructive hydrocephalus. The delayed onset and resistance to pharmacologic therapy emphasize the diagnostic and therapeutic complexity of HT. Clinicians should be vigilant in recognizing this condition in similar clinical scenarios and consider a tailored strategy, including delayed consideration of functional neurosurgery once hydrocephalus has stabilized.